Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone for Opioid-Induced Constipation in Orthopedic Rehabilitation
NCT00640146Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Oct 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylnaltrexone in opioid-induced constipation (OIC), sponsored by Valeant Pharmaceuticals. Started Oct 2007; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT00640146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640146.